Further corroborating the involvement of PARP-1 activity in these effects, we observed similar results by silencing PARP-1 expression in MCF7 (Fig. 3E-H) and T47D (Fig. 3I-L) ERα wild type and Y537S mutated BC cells. This evidence concerns the gene ESR1 and breast cancer.